-2.34%
Today
Loading 1D prices…
Company profile
Mobia Medical, Inc. develops and commercializes neurostimulation medical devices, including implantable systems for stroke rehabilitation and other neurological conditions. The company provides neurostimulation systems and devices that combine vagus nerve stimulation with therapy to address chronic neurological conditions. Its main product, the Vivistim System, is an FDA-approved implantable device designed to aid in the rehabilitation of upper limb motor function in post-stroke patients. The paired VNS platform is used to help patients relearn movements and improve motor deficits, and it is being developed for additional chronic neurologic conditions such as tinnitus. The company supports healthcare professionals, patients, and caregivers with information and resources related to its offerings. The company serves healthcare professionals and organizations involved in stroke rehabilitation and chronic neurological conditions, as well as patients and caregivers within the healthcare sector. The company was founded in 2007 and is based in Austin, Texas.
Sector
Health Care
Industry
Surgical & Medical Instruments & Apparatus
Exchange
Nasdaq
Display currency
USD
Location
Austin, TX, United States
Employees
167
Fiscal year end
1231
CIK
1489993
Session & valuation
Latest annual period
Deterministic peer set
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| OFIXOrthofix Medical Inc. Common Stock (DE) | $361M | $822.3M | -11.21% | -$2.33 | +2.65% | Buy |
| RCELAvita Medical Inc. Common Stock | $305.6M | $71.6M | -67.85% | -$1.74 | +0.20% | Buy |
| OBIOOrchestra BioMed Holdings Inc. Ordinary Shares | $367.8M | $33.5M | -157.40% | -$1.11 | +5.51% | Buy |
| TMCITreace Medical Concepts Inc. Common Stock | $293.3M | $212.7M | -27.74% | -$0.93 | +4.14% | Hold |
| SIShoulder Innovations Inc. Common Stock | $385.8M | $47.3M | -85.29% | -$4.65 | -3.04% | Buy |